Stay updated on Nivolumab & Cabozantinib vs Sunitinib in Renal Cell Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Nivolumab & Cabozantinib vs Sunitinib in Renal Cell Carcinoma Clinical Trial page.

Latest updates to the Nivolumab & Cabozantinib vs Sunitinib in Renal Cell Carcinoma Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRevision: v3.4.2 replaces v3.4.1. The update does not alter study details or other content visible on the page.SummaryDifference0.0%

- Check20 days agoChange DetectedA new Publication entry was added under Publications: Partitioned overall survival: comprehensive analysis of survival states over 4 years in CheckMate 9ER (J Immunother Cancer, 2026). The page revision was updated from v3.4.0 to v3.4.1.SummaryDifference0.0%

- Check27 days agoChange DetectedShow glossary toggle added; new labels include 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and 'Revision: v3.4.0' while the previous entries 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' were removed; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check42 days agoChange DetectedThe page shows a new revision label: Revision: v3.3.4, replacing v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check63 days agoChange DetectedAdded extensive Location sections listing study sites by country/region (e.g., United States by state, Argentina provinces, Australia states, Mexico regions, etc.), and noted the Revision: v3.3.3.SummaryDifference2%

- Check91 days agoChange DetectedUpdated page copy notes that PubMed publications are automatically filled in from a public database and adds the revision label v3.3.2. The previous PubMed-related wording has been replaced with updated language indicating automatic PubMed linkage and the older revision label v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Nivolumab & Cabozantinib vs Sunitinib in Renal Cell Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab & Cabozantinib vs Sunitinib in Renal Cell Carcinoma Clinical Trial page.